PTSD memory rewrite study for teens pulled before it began
NCT ID NCT04921982
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 38 times
Summary
This study aimed to see if propranolol, a blood pressure medicine, could reduce PTSD symptoms in teenagers by interfering with the way traumatic memories are re-stored in the brain. It planned to enroll 12- to 18-year-olds with PTSD for at least three months. However, the study was withdrawn before any participants were enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST-TRAUMATIC STRESS DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AP-HP Louis Mourier
Colombes, France
-
CH Bohars
Bohars, France
-
CH Guillaume Régnier
Rennes, 35000, France
-
CH Le Havre
Le Havre, France
-
CHU Angers
Angers, France
-
CHU Besançon
Besançon, France
-
CHU Limoges
Limoges, France
-
CHU Nantes
Nantes, France
-
CHU Poitiers
Poitiers, France
-
CHU Rouen
Rouen, France
Conditions
Explore the condition pages connected to this study.